Drug Registration and Acceptance

Drug Name

Exact

Active Ingredient

Acceptance No.

Manufacturers

Acceptance Date

Status Date

Classification

Review Status

Drug Type

Submission

Evaluation Conclusion

ATC Category

Special Approval Varieties

Task Type

Major Special Varieties

Sequence No.

Stock Code

Visualized Analysis Export Evaluation Conclusion Evaluation Progress

Acceptance No.	Drug Name	Active Ingredient	Dosage Form	Classification	Submission	Acceptance Date	Manufacturers	Manufacturers	Review Status	Status Date	View
CXL01M30	胸腺肽α1	thymalfasin	Active ingredient	Chemical Drugs(4)	New Drug Application	2004-02-27	中国人民解放军总医院科技开发中心	Science And Technology Development Center General Hospital Of The People'S Liberation Army	Certificate Issued	2004-07-12	view
CXL01M31	注射用胸腺肽α1	thymalfasin	Lyophilized	Chemical Drugs(4)	New Drug Application	2004-02-27	中国人民解放军总医院科技开发中心	Science And Technology Development Center General Hospital Of The People'S Liberation Army	Certificate Issued	2004-07-12	view
CXL01E93G	醋酸奥曲肽	Octreotide acetate	Active ingredient	Chemical Drugs(4)	New Drug Application	2002-03-12	中国人民解放军总医院科技开发中心	Science And Technology Development Center General Hospital Of The People'S Liberation Army	Approval Completed-Pending Certificated	2003-04-02	view
CXL01E94G	醋酸奥曲肽注射液	Octreotide acetate	Injection	Chemical Drugs(4)	New Drug Application	2002-03-12	中国人民解放军总医院科技开发中心	Science And Technology Development Center General Hospital Of The People'S Liberation Army	Approval Completed-Pending Certificated	2003-04-02	view
CXL00924	非那雄胺	finasteride	Active ingredient	Chemical Drugs(4)	New Drug Application	2001-01-12	中国人民解放军总医院科技开发中心	Science And Technology Development Center General Hospital Of The People'S Liberation Army	Pending Review	2000-12-27	view
CXL00925	非那雄胺片	finasteride	Tablet	Chemical Drugs(4)	New Drug Application	2001-01-12	中国人民解放军总医院科技开发中心	Science And Technology Development Center General Hospital Of The People'S Liberation Army	In Approval		view